Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2024-05-20 Report Publication Anno…
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
Notice of Results and AGM
Report Publication Announcement Classification · 99% confidence The document is an RNS announcement from Novacyt S.A. titled "Notice of Results and Annual General Meeting". It explicitly states the date the audited financial results for FY 2023 will be reported (May 30, 2024) and announces the date and time of the Annual General Meeting (AGM) (June 26, 2024). Since it announces the upcoming AGM and provides details about the meeting (virtual format, date), it directly relates to the AGM. Although it mentions the upcoming results release, the primary focus of the announcement structure is the AGM notice. Therefore, AGM-R (AGM Information) is the most appropriate classification, as it contains information pertaining to the meeting itself.
2024-05-20 English
Notice of Results and Annual General Meeting
AGM Information Classification · 99% confidence The document is titled "Notice of Results and Annual General Meeting". It explicitly announces two key future events: 1) The reporting of audited financial results for FY 2023 on May 30, 2024, and 2) The Annual General Meeting (AGM) to be held on June 26, 2024. Since this document is an announcement about the upcoming AGM and the release of results, and it is not the full AGM presentation material itself, nor is it the full Annual Report (10-K) or the Earnings Release (ER) which would contain the actual figures, it best fits the category for materials related to the AGM. The presence of the AGM date and the announcement of the results release date strongly points towards AGM-related preparatory or informational material. Given the explicit mention of the AGM, AGM-R is the most appropriate classification, even though it also mentions results.
2024-05-20 English
Avis sur les résultats et de convocation à l’Assemblée Générale Annuelle
AGM Information Classification · 98% confidence The document is titled "Avis sur les résultats et de convocation à l'Assemblée Générale Annuelle" (Notice of Results and Notice of Annual General Meeting). It explicitly announces two key events: the presentation of audited financial results for FY 2023 on May 30, 2024, and the Annual General Meeting (AGA/AGM) scheduled for June 26, 2024. Since the document serves as a formal notice combining the announcement of financial results (ER/MDA precursor) and the formal notice/agenda for the AGM, it strongly relates to the AGM process. However, the primary focus seems to be the dual announcement surrounding the AGM and the upcoming results presentation/webinar. Given the explicit mention of the 'Assemblée générale annuelle' (AGM) and the associated notice, 'AGM-R' (AGM Information) is the most fitting primary category, as it covers materials shared during the AGM, and this notice precedes it. It also mentions the upcoming results presentation, but the document itself is the notice/convocation, not the full results (ER) or the presentation (IP). Therefore, AGM-R is the best fit for a combined notice involving the AGM.
2024-05-20 French
Liquidity Agreement and Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a formal announcement released via RNS (Regulatory News Service) on May 2, 2024. The content primarily covers two specific items: 1) A monthly update on the company's liquidity agreement (share purchases/sales by the market maker) for April 2024, and 2) The announcement of the Total Voting Rights as of April 30, 2024, referencing French commercial code requirements. Announcements regarding share transactions (even those related to liquidity agreements) and the total number of voting rights are often related to capital structure or significant ownership changes. However, the core purpose here is a routine update on share buybacks under a liquidity agreement and the mandatory disclosure of total voting rights. This combination fits best under 'Transaction in Own Shares' (POS) due to the detailed share repurchase/holding data, or potentially 'Capital/Financing Update' (CAP). Given the explicit mention of shares purchased and sold under the Liquidity Agreement, and the resulting treasury shares, POS is the most precise fit for the primary transactional data disclosed. It is not a general regulatory filing (RNS) because it is highly specific, nor is it a Major Shareholding Notification (MRQ) as it reports on the company's own actions/status, not an external shareholder crossing a threshold. It is not a DIV, SHA, or DIRS. Therefore, POS is selected.
2024-05-02 English
DHSC application for summary judgment dismissed
Legal Proceedings Report Classification · 99% confidence The document begins with an 'RNS Number' and is dated May 1, 2024. It discusses a legal update regarding a DHSC application dismissal and sets a trial hearing date. The footer explicitly states, "This information is provided by RNS, the news service of the London Stock Exchange." RNS filings are general regulatory announcements. Since the content is a specific, non-financial update (legal proceedings update) that doesn't fit into the more specific categories like LTR (Legal Proceedings Report, which usually details the substance of the case rather than just procedural updates), or ER/IR (Earnings/Interim Reports), the most appropriate classification based on the source and nature of the announcement is the general regulatory filing category. Although it relates to legal proceedings, it is structured as a standard RNS announcement, making RNS the primary classification for this type of market disclosure.
2024-05-01 English
Rejet de la demande de jugement sommaire du DHSC
Legal Proceedings Report Classification · 99% confidence The document is a press release from Novacyt S.A. dated May 1, 2024, titled "Rejet de la demande de jugement sommaire du DHSC" (Rejection of the DHSC's summary judgment application). It discusses the outcome of a pre-trial review concerning a legal matter involving the Department of Health and Social Care (DHSC) and sets a date for the main trial. This content specifically relates to significant lawsuits or regulatory actions involving the company. Therefore, it fits the definition of a Legal Proceedings Report (LTR). It is not a full financial report (10-K, IR), an earnings announcement (ER), or a general regulatory filing (RNS), as it pertains to a specific legal development.
2024-05-01 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.